Equities Analysts Set Expectations for AARD FY2025 Earnings
Aardvark Therapeutics, Inc. (NASDAQ:AARD – Free Report) – Cantor Fitzgerald boosted their FY2025 EPS estimates for shares of Aardvark Therapeutics in a note issued to investors on Thursday, May 15th. Cantor Fitzgerald analyst J. Schimmer now expects that the company will post earnings of ($2.46) per share for the year, up from their prior forecast […]
Aardvark Therapeutics, Inc. (NASDAQ:AARD – Free Report) – Cantor Fitzgerald boosted their FY2025 EPS estimates for shares of Aardvark Therapeutics in a note issued to investors on Thursday, May 15th. Cantor Fitzgerald analyst J. Schimmer now expects that the company will post earnings of ($2.46) per share for the year, up from their prior forecast […]
